143 related articles for article (PubMed ID: 19553391)
1. Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site.
Lace MJ; Yamakawa Y; Ushikai M; Anson JR; Haugen TH; Turek LP
J Gen Virol; 2009 Oct; 90(Pt 10):2402-2412. PubMed ID: 19553391
[TBL] [Abstract][Full Text] [Related]
2. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
Dong XP; Pfister H
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
[TBL] [Abstract][Full Text] [Related]
3. Regulatory interactions of transcription factor YY1 with control sequences of the E6 promoter of human papillomavirus type 8.
Pajunk HS; May C; Pfister H; Fuchs PG
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3287-95. PubMed ID: 9400979
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
6. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6.
Ai W; Narahari J; Roman A
J Virol; 2000 Jun; 74(11):5198-205. PubMed ID: 10799595
[TBL] [Abstract][Full Text] [Related]
7. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.
Peña N; Carrillo D; Muñoz JP; Chnaiderman J; Urzúa U; León O; Tornesello ML; Corvalán AH; Soto-Rifo R; Aguayo F
PLoS One; 2015; 10(4):e0123029. PubMed ID: 25830243
[TBL] [Abstract][Full Text] [Related]
8. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
9. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16.
Tan SH; Baker CC; Stünkel W; Bernard HU
Virology; 2003 Jan; 305(2):486-501. PubMed ID: 12573593
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site.
Ralph WM; Liu K; Auborn KJ
J Gen Virol; 2006 Jan; 87(Pt 1):51-59. PubMed ID: 16361417
[TBL] [Abstract][Full Text] [Related]
11. A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA.
Glahder JA; Hansen CN; Vinther J; Madsen BS; Norrild B
J Gen Virol; 2003 Dec; 84(Pt 12):3429-3441. PubMed ID: 14645924
[TBL] [Abstract][Full Text] [Related]
12. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
13. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition.
Zhan D; Santin AD; Liu Y; Parham GP; Li C; Meyers C; Hermonat PL
J Biol Chem; 1999 Oct; 274(44):31619-24. PubMed ID: 10531369
[TBL] [Abstract][Full Text] [Related]
14. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang SM; McCance DJ
J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
[TBL] [Abstract][Full Text] [Related]
15. A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter.
Bauknecht T; Jundt F; Herr I; Oehler T; Delius H; Shi Y; Angel P; Zur Hausen H
J Virol; 1995 Jan; 69(1):1-12. PubMed ID: 7983700
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.
Lace MJ; Anson JR; Haugen TH; Turek LP
Virology; 2010 Apr; 399(2):270-9. PubMed ID: 20129639
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor YY1 is a vaccinia virus late promoter activator.
Broyles SS; Liu X; Zhu M; Kremer M
J Biol Chem; 1999 Dec; 274(50):35662-7. PubMed ID: 10585445
[TBL] [Abstract][Full Text] [Related]
19. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence.
Peralta-Zaragoza O; Bermúdez-Morales V; Gutiérrez-Xicotencatl L; Alcocer-González J; Recillas-Targa F; Madrid-Marina V
Viral Immunol; 2006; 19(3):468-80. PubMed ID: 16987065
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
